Insiders · IMRX

IMRX insider transactions

Immuneering Corporation (IMRX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for IMRX

• 85d
  CHIEF PEOPLE OFFICER Neufeld Leah R was granted 3,628 shares, increasing direct ownership by 14% to 29,598 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 126d
  SEC Form 4 filed by CHIEF LEGAL OFFICER, SECRETARY Bookman Michael

  4 - Immuneering Corp (0001790340) (Issuer)
• 126d
  SEC Form 4 filed by Chief Business Officer Brakewood Harold Eugene

  4 - Immuneering Corp (0001790340) (Issuer)
• 126d
  SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Hall Brett Matthew

  4 - Immuneering Corp (0001790340) (Issuer)
• 126d
  SEC Form 4 filed by Chief Medical Officer Matushansky Igor

  4 - Immuneering Corp (0001790340) (Issuer)
• 126d
  SEC Form 4 filed by SVP Finance, CAO Morales Mallory

  4 - Immuneering Corp (0001790340) (Issuer)
• 126d
  SEC Form 4 filed by CHIEF PEOPLE OFFICER Neufeld Leah R

  4 - Immuneering Corp (0001790340) (Issuer)
• 126d
  SEC Form 4 filed by PRESIDENT AND CEO Zeskind Benjamin J.

  4 - Immuneering Corp (0001790340) (Issuer)
• 141d
  Chief Business Officer Brakewood Harold Eugene bought $24,990 worth of shares (5,250 units at $4.76), increasing direct ownership by 91% to 11,050 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 142d
  Director Schall Thomas J. bought $101,041 worth of shares (21,645 units at $4.67), increasing direct ownership by 41% to 74,530 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 145d
  CHIEF SCIENTIFIC OFFICER Hall Brett Matthew bought $10,502 worth of shares (2,298 units at $4.57), increasing direct ownership by 0.61% to 376,496 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 147d
  CHIEF PEOPLE OFFICER Neufeld Leah R bought $10,906 worth of shares (2,626 units at $4.15), increasing direct ownership by 11% to 25,970 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 148d
  Director Feinberg Peter bought $86,904 worth of shares (20,000 units at $4.35) (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 159d
  SEC Form 4 filed by Director Keating Laurie

  4 - Immuneering Corp (0001790340) (Issuer)
• 159d
  SEC Form 4 filed by Director Feinberg Peter

  4 - Immuneering Corp (0001790340) (Issuer)
• 247d
  Director Feinberg Peter bought $50,025 worth of shares (7,500 units at $6.67), increasing direct ownership by 5% to 156,766 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 252d
  Chief Accounting Officer Morales Mallory bought $1,917 worth of shares (300 units at $6.39), increasing direct ownership by 1% to 27,533 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 252d
  CHIEF PEOPLE OFFICER Neufeld Leah R bought $5,103 worth of shares (800 units at $6.38), increasing direct ownership by 4% to 23,344 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 252d
  CHIEF LEGAL OFFICER, SECRETARY Bookman Michael bought $6,966 worth of shares (1,020 units at $6.83), increasing direct ownership by 26% to 4,870 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 253d
  Director Feinberg Peter bought $52,730 worth of shares (7,500 units at $7.03), increasing direct ownership by 5% to 149,266 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 254d
  Director Feinberg Peter bought $35,900 worth of shares (5,000 units at $7.18), increasing direct ownership by 4% to 141,766 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 266d
  CHIEF PEOPLE OFFICER Neufeld Leah R was granted 11,815 shares, increasing direct ownership by 110% to 22,544 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 266d
  Chief Accounting Officer Morales Mallory was granted 14,497 shares, increasing direct ownership by 114% to 27,233 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 266d
  CHIEF SCIENTIFIC OFFICER Hall Brett Matthew was granted 14,880 shares, increasing direct ownership by 4% to 374,198 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 339d
  Director Hausman Diana bought $19,862 worth of shares (5,500 units at $3.61) (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 339d
  CHIEF PEOPLE OFFICER Neufeld Leah R bought $2,499 worth of shares (700 units at $3.57), increasing direct ownership by 7% to 10,729 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 343d
  PRESIDENT AND CEO Zeskind Benjamin J. bought $34,879 worth of shares (10,000 units at $3.49), increasing direct ownership by 0.43% to 2,312,852 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 346d
  Director Schall Thomas J. bought $34,788 worth of shares (9,500 units at $3.66), increasing direct ownership by 22% to 52,885 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 352d
  CHIEF SCIENTIFIC OFFICER Hall Brett Matthew bought $34,616 worth of shares (13,422 units at $2.58), increasing direct ownership by 4% to 359,318 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 352d
  Chief Business Officer Brakewood Harold Eugene bought $4,804 worth of shares (1,900 units at $2.53), increasing direct ownership by 49% to 5,800 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 353d
  Director Feinberg Peter bought $63,188 worth of shares (25,000 units at $2.53), increasing direct ownership by 22% to 136,766 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 356d
  PRESIDENT AND CEO Zeskind Benjamin J. bought $50,144 worth of shares (21,000 units at $2.39), increasing direct ownership by 0.92% to 2,302,852 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 358d
  Director Schall Thomas J. bought $89,278 worth of shares (40,485 units at $2.21), increasing direct ownership by 1,396% to 43,385 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 360d
  SEC Form 4 filed by Director Hausman Diana

  4 - Immuneering Corp (0001790340) (Issuer)
• 360d
  SEC Form 4 filed by Director Schall Thomas J.

  4 - Immuneering Corp (0001790340) (Issuer)
• 360d
  SEC Form 4 filed by Director Keating Laurie

  4 - Immuneering Corp (0001790340) (Issuer)
• 360d
  SEC Form 4 filed by Director Feinberg Peter

  4 - Immuneering Corp (0001790340) (Issuer)
• 360d
  SEC Form 4 filed by Director Carpenter Robert J

  4 - Immuneering Corp (0001790340) (Issuer)
• 360d
  SEC Form 4 filed by Director Berman Ann E

  4 - Immuneering Corp (0001790340) (Issuer)
• 443d
  SEC Form 4 filed by Chief Medical Officer Matushansky Igor

  4 - Immuneering Corp (0001790340) (Issuer)
• 443d
  SEC Form 3 filed by new insider Matushansky Igor

  3 - Immuneering Corp (0001790340) (Issuer)
• 488d
  SEC Form 4 filed by Chief Accounting Officer Morales Mallory

  4 - Immuneering Corp (0001790340) (Issuer)
• 488d
  SEC Form 4 filed by CHIEF PEOPLE OFFICER Neufeld Leah R

  4 - Immuneering Corp (0001790340) (Issuer)
• 488d
  SEC Form 4 filed by Chief Business Officer Brakewood Harold Eugene

  4 - Immuneering Corp (0001790340) (Issuer)
• 488d
  SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Hall Brett Matthew

  4 - Immuneering Corp (0001790340) (Issuer)
• 488d
  SEC Form 4 filed by PRESIDENT AND CEO Zeskind Benjamin J.

  4 - Immuneering Corp (0001790340) (Issuer)
• 488d
  SEC Form 4 filed by CHIEF LEGAL OFFICER, SECRETARY Bookman Michael

  4 - Immuneering Corp (0001790340) (Issuer)
• 524d
  SEC Form 4 filed by Director Berman Ann E

  4 - Immuneering Corp (0001790340) (Issuer)
• 524d
  SEC Form 4 filed by Director Feinberg Peter

  4 - Immuneering Corp (0001790340) (Issuer)
• 524d
  SEC Form 4 filed by Director Keating Laurie

  4 - Immuneering Corp (0001790340) (Issuer)
• 631d
  Chief Accounting Officer Morales Mallory was granted 4,458 shares, increasing direct ownership by 54% to 12,736 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 727d
  SEC Form 4 filed by Director Schall Thomas J.

  4 - Immuneering Corp (0001790340) (Issuer)
• 727d
  SEC Form 4 filed by Director Keating Laurie

  4 - Immuneering Corp (0001790340) (Issuer)
• 727d
  SEC Form 4 filed by Director Carpenter Robert J

  4 - Immuneering Corp (0001790340) (Issuer)
• 727d
  SEC Form 4 filed by Director Feinberg Peter

  4 - Immuneering Corp (0001790340) (Issuer)
• 727d
  SEC Form 4 filed by Director Berman Ann E

  4 - Immuneering Corp (0001790340) (Issuer)
• 727d
  SEC Form 4 filed by Director Hausman Diana

  4 - Immuneering Corp (0001790340) (Issuer)
• 748d
  SEC Form 4 filed by Bookman Michael

  4 - Immuneering Corp (0001790340) (Issuer)
• 748d
  SEC Form 4 filed by Morales Mallory

  4 - Immuneering Corp (0001790340) (Issuer)
• 748d
  SEC Form 4 filed by Brakewood Harold Eugene

  4 - Immuneering Corp (0001790340) (Issuer)